Browse the evidence

Other relevant nutritional interventions for NAFLD include food selection and time-restricted eating.

Incorporating food selection and time-restricted eating may benefit NAFLD management.

Liquid meal replacements lead to a mean reduction in HbA1c of −0.43% (−4.7 mmol/mol [−7.2 to −2.1]).

Liquid meal replacements may help improve glycemic control in individuals with type 2 diabetes.

Forty-one patients (52.6%) in the surgery group had complete remission of diabetes, while no patient in the control group had remission.

Surgical intervention may lead to significant diabetes remission in eligible patients.

Effective treatment of obesity is necessary to reduce the associated burdens of diabetes mellitus, cardiovascular disease, and death.

Practitioners should prioritize obesity treatment to mitigate serious health risks.

Weight loss interventions can impact both traditional and novel cardiovascular disease risk factors.

Weight loss strategies should consider their effects on cardiovascular health.

Ingestion of medium-chain triacylglycerols in combination with carbohydrate spares muscle carbohydrate stores during 2 hours of submaximal cycling exercise and improves 40 km time-trial performance.

Endurance athletes may benefit from combining medium-chain triacylglycerols with carbohydrates to enhance performance.

Dietary fat adaptation for a period of at least 2-4 weeks has resulted in a nearly two-fold increase in resistance to fatigue during prolonged, low- to moderate-intensity cycling.

Athletes may improve their endurance by adapting to a high-fat diet over several weeks.

Mean cycling 20 km time-trial performance is enhanced by 80 seconds after dietary fat adaptation and 3 days of carbohydrate loading.

Combining dietary fat adaptation with carbohydrate loading can significantly enhance time-trial performance.

A 13% weight loss in patients with type 2 diabetes was accompanied by a 46% improvement in insulin sensitivity.

Weight loss can significantly improve insulin sensitivity in individuals with type 2 diabetes.

The low-carbohydrate diet intervention group had a significantly greater 6-month reduction in HbA1c of -0.23% compared to the usual diet group.

A low-carbohydrate diet may be effective in reducing HbA1c levels in individuals with prediabetes or untreated diabetes.

The low-carbohydrate diet intervention group experienced a significant reduction in fasting plasma glucose of -10.3 mg/dL.

Implementing a low-carbohydrate diet may help lower fasting plasma glucose levels in individuals with prediabetes or untreated diabetes.

Primary prevention of type 2 diabetes (T2D) should be achievable through the implementation of early and sustainable measures.

Implement early and sustainable prevention measures for at-risk individuals.

Cholesterol reduction combined with aggressive management of modifiable risk factors can help reduce and prevent morbidity and mortality in individuals at increased risk of cardiovascular events.

Practitioners should focus on cholesterol reduction and managing lifestyle factors to improve cardiovascular health.

Therapeutic lifestyle change is the mainstay of management for all patients with dyslipidaemia.

Healthcare providers should prioritize lifestyle modifications in treating dyslipidaemia.

Weight loss and fat mass loss through lifestyle and pharmacologic interventions improve metabolic and inflammatory markers, suggesting a link to decreased breast cancer risk.

Practitioners should encourage weight loss and fat mass reduction as strategies to lower breast cancer risk.

bMVPA performed in the afternoon is associated with a greater reduction in HbA1c compared to inactive individuals, with a reduction of -0.22%.

Practitioners may consider recommending afternoon physical activity to improve glycemic control in patients with type 2 diabetes.

Therapeutic strategies that promote significant and sustained weight loss (~10% of total body weight) are among the most efficient for treating NASH and T2D.

Weight loss interventions should be prioritized in managing NASH and T2D.

The risk of major adverse cardiovascular events (MACE) decreases after approximately 10% of weight loss in patients who underwent metabolic surgery.

Practitioners should aim for at least 10% weight loss in surgical patients to reduce cardiovascular risk.

A threshold of approximately 5% weight loss is associated with reduced all-cause mortality in patients who underwent metabolic surgery.

Practitioners should encourage at least 5% weight loss in surgical patients to improve survival rates.

Ingestion of many protein sources in temporal proximity to resistance exercise increases muscle protein synthesis (MPS) resulting in positive net muscle protein balance (NMPB).

Practitioners should encourage protein intake close to resistance training for optimal muscle growth.

Total cholesterol, low-density lipoprotein cholesterol, and C-reactive protein levels significantly decreased in the A allele group after treatment with diet II.

Diet II may lead to improved lipid profiles in A allele carriers.

Readers are advised to get organized, eat less, eat better, move more, and get political.

Implementing these strategies can lead to better health outcomes.

Fasting lipid parameters are generally improved by low-carbohydrate diets.

Practitioners should consider the quality of fats in low-carbohydrate diets when assessing lipid improvements.

Weight loss (10%) in obese hypertensive subjects resulted in substantial improvements in blood pressure, insulin sensitivity, and lipid profile.

Practitioners should consider weight loss as a viable intervention for improving blood pressure and metabolic health in obese hypertensive patients.